CLINICAL-EVALUATION OF HIGH-DOSE CYTARABINE AND CISPLATIN IN RECURRENT CERVICAL-CARCINOMA

被引:0
|
作者
KEENEY, ED
FREEDMAN, RS
DREWINKO, B
RUTLEDGE, FN
ATKINSON, EN
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOSTAT,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT GYNECOL,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT LAB MED,HOUSTON,TX 77030
来源
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 09期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1023 / 1025
页数:3
相关论文
共 50 条
  • [21] SYMPTOMATOLOGY, LOCALIZATION AND TREATMENT OF RECURRENT CERVICAL-CARCINOMA
    TINGA, DJ
    BOUMA, J
    BOONSTRA, H
    AALDERS, JG
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1992, 2 (04) : 179 - 188
  • [22] CONCOMITANT CISPLATIN AND RADIOTHERAPY IN LOCALLY ADVANCED CERVICAL-CARCINOMA
    RUNOWICZ, CD
    WADLER, S
    RODRIGUEZRODRIGUEZ, L
    LITWIN, P
    SHAVES, M
    OHANLAN, KA
    GOLDBERG, GL
    TOMAINO, CT
    BYRNES, R
    GYNECOLOGIC ONCOLOGY, 1989, 34 (03) : 395 - 401
  • [23] CYTARABINE - LOW-DOSE, HIGH-DOSE, NO DOSE
    DESFORGES, JF
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (26): : 1637 - 1639
  • [24] PHYSICIANS WARNED OF HIGH-DOSE CYTARABINE
    MAHANEY, FX
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (04) : 259 - 261
  • [25] The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin
    Umino, Kento
    Hatano, Kaoru
    Ochi, Shin-ichi
    Genda, Harunobu
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Mashima, Kiyomi
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Morita, Kaoru
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Sato, Kazuya
    Oh, Iekuni
    Fujiwara, Shin-ichiro
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (03) : 396 - 400
  • [26] EVALUATION ORF THE SCALENE LYMPH-NODES IN PRIMARY AND RECURRENT CERVICAL-CARCINOMA
    BURKE, TW
    HELLER, PB
    HOSKINS, WJ
    WEISER, EB
    NASH, JD
    PARK, RC
    GYNECOLOGIC ONCOLOGY, 1987, 28 (03) : 312 - 317
  • [27] PHASE-I STUDY OF HIGH-DOSE CYTARABINE AND CISPLATIN IN PATIENTS WITH ADVANCED MALIGNANCY
    ATKINS, JN
    MUSS, HB
    CAPIZZI, RL
    COOPER, MR
    CRAIG, J
    CRUZ, JM
    JACKSON, DV
    POWELL, B
    RICHARDS, F
    SPURR, CL
    STUART, JJ
    WHITE, DR
    ZEKAN, P
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 897 - 899
  • [28] DOSE-RATE STUDIES IN CERVICAL-CARCINOMA
    HUNTER, RD
    BRITISH JOURNAL OF RADIOLOGY, 1985, 58 (692): : 804 - 804
  • [29] The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin
    Kento Umino
    Kaoru Hatano
    Shin-ichi Ochi
    Harunobu Genda
    Takashi Ikeda
    Shin-ichiro Kawaguchi
    Yumiko Toda
    Shoko Ito
    Takashi Nagayama
    Kiyomi Mashima
    Daisuke Minakata
    Hirofumi Nakano
    Ryoko Yamasaki
    Kaoru Morita
    Chihiro Yamamoto
    Masahiro Ashizawa
    Kazuya Sato
    Iekuni Oh
    Shin-ichiro Fujiwara
    Ken Ohmine
    Kazuo Muroi
    Yoshinobu Kanda
    International Journal of Hematology, 2020, 111 : 396 - 400
  • [30] RHABDOMYOLYSIS ASSOCIATED WITH HIGH-DOSE CYTARABINE
    MARGOLIS, D
    ROSS, E
    MILLER, KB
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1325 - 1326